CollPlant Biotechnologies...

NASDAQ: CLGN · Real-Time Price · USD
2.50
-0.11 (-4.21%)
At close: Aug 15, 2025, 3:57 PM
2.56
2.40%
After-hours: Aug 15, 2025, 06:26 PM EDT

CollPlant Biotechnologies Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.47M 515K 650K 689K 10.62M 10.96M 10.72M 10.78M 666K 299K 551K 582K 1.21M 15.64M 15.89M 19.9M 20.03M
Cost of Revenue
1.27M 1.91M 2.69M 2.7M 2.77M 2.27M 1.28M 1.27M 694K 400K 886K 764K 1.15M 2M 1.79M 3.09M 3.41M
Gross Profit
1.2M -1.39M -2.04M -2.01M 7.85M 8.68M 9.44M 9.52M -28K -101K -335K -182K 57K 13.64M 14.09M 16.8M 16.61M
Operating Income
-14.57M -17.25M -18.34M -18.41M -8.32M -7.51M -7.12M -6.99M -16.85M -17.1M -16.23M -14.85M -13.73M 65K 1.16M 4.98M 6.13M
Interest Income
604K 738K 1.33M 1.34M 1.23M 1.29M 781K 645K 560K 364K 119K 97K 169K 219K 212K 145K 82K
Pretax Income
-13.87M -16.61M -17.42M -17.47M -7.5M -7.02M -6.73M -6.73M -16.78M -16.93M -16.3M -14.99M -13.75M 237K 1.1M 4.88M 5.95M
Net Income
-13.87M -16.61M -17.42M -17.47M -7.5M -7.21M -6.65M -6.57M -16.71M -16.75M -16.4M -15.19M -13.84M 237K 1.1M 4.88M 5.95M
Selling & General & Admin
5.56M 5.35M 5.22M 5.49M 5.38M 5.71M 6.55M 6.41M 6.71M 6.74M 6.08M 5.73M 5.55M 5.94M 6.12M 5.98M 5.54M
Research & Development
10.21M 10.52M 11.09M 10.91M 10.79M 10.48M 10.01M 10.09M 10.12M 10.26M 9.81M 8.94M 8.24M 7.63M 6.77M 5.79M 4.89M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
15.77M 15.86M 16.3M 16.4M 16.17M 16.2M 16.56M 16.5M 16.82M 17M 15.89M 14.67M 13.79M 13.57M 12.94M 11.82M 10.48M
Interest Expense
17K 17K 10K 10K 10K 206K 196K 285K 385K 281K 283K 202K 110K 37K 61K 64K 58K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.04M 17.77M 19M 19.09M 18.95M 18.47M 17.84M 17.77M 17.51M 17.4M 16.78M 15.43M 14.94M 15.58M 14.73M 14.91M 13.89M
Income Tax Expense
n/a n/a n/a n/a n/a 196K -79K -168K -68K -172K 103K 217K 117K 44K 44K 19K 19K
Shares Outstanding (Basic)
11.45M 11.45M 11.45M 11.45M 11.45M 11.45M 11.44M 11.37M 11.27M 11.19M 11.09M 11.09M 10.78M 10.73M 10.5M 10.2M 8.41M
Shares Outstanding (Diluted)
11.45M 11.45M 11.45M 11.45M 11.45M 11.45M 11.44M 11.78M 11.27M 11.19M 11.09M 11.09M 10.78M 10.73M 10.5M 10.2M 11.5M
EPS (Basic)
-1.22 -1.46 -1.53 -1.53 -0.65 -0.63 -0.59 -0.6 -1.51 -1.53 -1.51 -1.41 -1.31 0.26 0.19 0.58 0.60
EPS (Diluted)
-1.22 -1.46 -1.53 -1.53 -0.67 -0.65 -0.61 -0.62 -1.51 -1.53 -1.51 -1.41 -1.31 -0.06 -0.13 0.23 0.25
EBITDA
-13.57M -16.21M -17.27M -17.31M -7.22M -6.41M -6.01M -5.87M -15.73M -16.02M -15.19M -13.9M -12.82M 903K 1.9M 5.68M 6.78M
EBIT
-14.57M -17.25M -18.34M -18.41M -8.24M -7.43M -7.04M -6.9M -16.85M -17.1M -16.19M -14.82M -13.66M 130K 1.16M 4.99M 6.05M
Depreciation & Amortization
1M 1.04M 1.08M 1.1M 1.1M 1.1M 1.11M 1.12M 1.12M 1.08M 1.01M 922K 840K 773K 715K 685K 669K